↓ Skip to main content

Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats

Overview of attention for article published in Cardiovascular Diabetology, September 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats
Published in
Cardiovascular Diabetology, September 2012
DOI 10.1186/1475-2840-11-105
Pubmed ID
Authors

Jing Lu, Yu-yu Yao, Qi-ming Dai, Gen-shan Ma, Shu-feng Zhang, Lei Cao, Li-qun Ren, Nai-feng Liu

Abstract

Recent studies revealed that erythropoietin (EPO) has tissue-protective effects in the heart by increasing vascular endothelial growth factor (VEGF) expression and attenuating myocardial fibrosis in ischemia models. In this study, we investigated the effect of EPO on ventricular remodeling and blood vessel growth in diabetic rats.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 2%
Unknown 47 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 23%
Researcher 7 15%
Student > Master 7 15%
Student > Bachelor 3 6%
Lecturer 3 6%
Other 8 17%
Unknown 9 19%
Readers by discipline Count As %
Medicine and Dentistry 18 38%
Agricultural and Biological Sciences 8 17%
Biochemistry, Genetics and Molecular Biology 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Decision Sciences 1 2%
Other 3 6%
Unknown 11 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 September 2012.
All research outputs
#20,166,700
of 22,678,224 outputs
Outputs from Cardiovascular Diabetology
#1,199
of 1,363 outputs
Outputs of similar age
#150,859
of 169,032 outputs
Outputs of similar age from Cardiovascular Diabetology
#9
of 10 outputs
Altmetric has tracked 22,678,224 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,363 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,032 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one.